AzTrials
AzTrials

Pulpitis - IrreversibleNCT03956199

Pulpotomy vs.Root Canal Treatment in Managing Irreversible Pulpitis

A study testing pulpotomy and Root canal treatment in people with Pulpitis - Irreversible, run by King's College London at 3 sites in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aims to compare two methods of repairing and saving a badly damaged or infected tooth. One method is called root canal treatment (RoCT) and the other (new method) is called pulpotomy. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Pulpitis - Irreversible
What is being tested?
pulpotomy and Root canal treatment
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
168 participants
Where
3 sitesUnited Kingdom
Study dates
1 Sep 2019to 1 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • • Dental patients from an acute (secondary care) setting from at least three UK centres (including King's College London Dental Institute, Denmark Hill and Liverpool).
  • Male or female (aged >16) able to provide informed consent in otherwise good general health with at least one molar tooth with clinical symptoms of irreversible pulpitis caused by caries, requiring RoCT (endodontic treatment).
  • Patients enrolled will have clinical symptoms of irreversible pulpitis who need treatment.

Who cannot join

  • The presence of fistulas or swelling
  • Anterior teeth or premolars
  • External or internal root resorption
  • Multiple teeth with carious lesions in the same quadrant,
  • Pregnant women, in view of requirements for radiographs.
  • Patients younger than 16.
Show all 10Show fewer
  • Patients unable to give consent.
  • Patients who have been administered antibiotics in the previous month.
  • Immunocompromised patients
  • Teeth with hopeless prognosis with caries extended into root dentine and with tooth margin at crestal bone level

Trial locations and contacts

3 sites in 1 country.

United Kingdom3 sites, 2 recruiting
  • Royal Liverpool University Hospital

    Liverpool, L78XP

    Active, not recruiting
  • Guy's Hospital

    London, SE19RT

    Francesco Mannocci, Prof, 02011881573, francesco.mannocci@kcl.ac.uk

    Tiago Pimentel

    Recruiting
  • King's College Hospital

    London, SE5 9RS

    Francesco Mannocci, 02011881573, francesco.mannocci@kcl.ac.uk

    Tiago Pimentel

    Recruiting

Other trials in United Kingdom

About this study

Official title: Managing Irreversible Pulpitis - The Effectiveness of Pulpotomy Compared to Root Canal Treatment as a Replacement for Conventional Root Canal Treatment: A Multicentre Randomized Controlled Trial

The study aims to compare two methods of repairing and saving a badly damaged or infected tooth. One method is called root canal treatment (RoCT) and the other (new method) is called pulpotomy. RoCT involves removing the damaged area of the tooth including the tooth nerve (called the pulp), cleaning, disinfecting and sealing it. Pulpotomy however attempts to preserve as much of the tooth nerve as possible (keeping the tooth alive). RoCT is more expensive and painful. Therefore, some patients delay or avoid getting treated, resulting in later complications treated in an emergency setting. This research will aim to show that pulpotomy is less painful, less involved (i.e. less invasive), less time consuming and consequently more cost effective. Long term costs of dental treatment as well as the improved quality of life will therefore offer benefits for patients, public and the NHS who use dental services. Caries (tooth decay) is the most common diseases in the world. The NHS spends at least £3.4 billion per year on dental visits or at dental hospitals. This does not include private (societal) costs to individuals who do not qualify for NHS dental treatment. Consequently, those who end up avoiding or delaying treatment result in complications often treated through the NHS. We have therefore chosen a randomized controlled trial design, a gold standard method to compare the effectiveness of the two treatment options. The participants will be 168 dental patients (male or female) from different parts (London and Liverpool) of the UK so that results can be generalized. This design was considered in consultation with a member of the public (a co-applicant) who will be involved in the trial from the start to completion. The results will be published and discussed at conferences as well as through our patient and public network.

Being tested
pulpotomy, Root canal treatment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pulpotomyProcedure or surgery

    removal of the pulp from pulp chamber

  • Root canal treatmentProcedure or surgery

    Removal of at the entire content of the root canal system and root canal obturation

Study groups in NCT03956199
Study groupRoleWhat they receive
experimental pulpotomyExperimentalNot described
Receives: Procedure: pulpotomy
Root canal treatmentActive comparatorNot described
Receives: Procedure: Root canal treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Short term pain following pulpotomy versus root canal treatment

    Pain, tenderness or swelling assessment at baseline and over the first 7 days post completion of treatment using a daily diary of pain (based on a 10 point visual analogue (VAS Scale), measured using the area under the curve (AUC) approach).

    Measured: 7 days

Secondary outcomes (4)
  1. Cost-effectiveness of pulpotomy

    • Health care resource use between randomization and 12 months post randomization for assessing the cost-effectiveness of pulpotomy in comparison to RCT as measured by the incremental cost-effectiveness ratio (ICER) in terms of the INMB

    Measured: 2 years

  2. sensitivity and specificity of CBCT versus periodical radiographs to detect periapical radiolucencies

    the sensitivity and specificity of periapical radiograph (clinical standard) to CBCT (experimental) in terms of detection of periapical disease.

    Measured: 2 years

  3. success rates of pulpotomy compared to root canal treatment

    The vitality or absence of apical pathology of the tooth at 24 months: that is, an absence of either pain, swelling or tenderness to biting of the tooth and no evi-dence of inflammation in the tissues around the tip of the root detected by con-ventional radiographs and CBCT (independent assessors) after 24 months from randomisation. Both assessors must agree to conclude an overall absence of apical pathology. Treatment outcome will be assessed objectively using scans taken pre-treatment and and follow-up (6,12,24 months) appointments.

    Measured: 2 years

  4. Quality of life difference between patients that receive pulpotomy versus root canal treatment

    • The EQ-5D-3L and EQ-5D-5L measured at baseline, over the first 7 days, 6 and 12 months post randomisation. One major feature of the EQ-5D tool is that the health states obtained from the questionnaire may be con-verted into a single index value with country specific value sets. This will facilitate the calculation and comparison of quality-adjusted life years (QALYs) between pulpotomy vs. primary root canal treatment. The QALY is a measure of disease burden including the quality and quantity of life lived, with one QALY equating to one year in perfect health

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2019
  2. Study start1 Sep 2019
  3. Primary completion1 Apr 2023 (estimated)
  4. Study completion1 Apr 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
168 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03956199
Sponsor's protocol ID
PB-PG-0817-20040
Status last verified
Nov 2020
First submitted
14 May 2019
Last updated
12 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Patel N, Khan I, Jarad F, Zavattini A, Koller G, Pimentel T, Mahmood K, Mannocci F. The short-term postoperative pain and impact upon quality of life of pulpotomy and root canal treatment, in teeth with symptoms of irreversible pulpitis: A randomized controlled clinical trial. Int Endod J. 2025 Jan;58(1):55-70. doi: 10.1111/iej.14144. Epub 2024 Sep 26.

    PubMed 39325552

Questions about this trial

What is this clinical trial studying?

A study testing pulpotomy and Root canal treatment in people with Pulpitis - Irreversible, run by King's College London at 3 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Short term pain following pulpotomy versus root canal treatment (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03956199, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in